Around half of vaccines are wasted each year globally, according to the World Health Organization. Many are lost because they get too hot or cold. The scale of the loss prompted scientists to work on fridge-free versions of common vaccines - and this week one such vaccine showed promise in a world-first trial.
For more than a decade, Elie observed and recorded the sounds the birds made and classified the calls according to the situation and the bird that made them. She then used machine learning to analyse what and how information was encoded in the calls. Finally, she ran tests that showed the birds agreed with her classification.
A research team from ETH Zurich and the University of Zurich (UZH) has developed a novel approach to treating spinal cord injuries: controllable microrobots deliver stem cells directly to the site of an injury, where they promote nerve cell regeneration. In animal experiments, this approach significantly improved mobility.
A Bangladeshi pharma company will soon release a generic version of an expensive drug for cystic fibrosis that will allow hundreds of patients worldwide to access treatment.
The vaccine appears to prime the immune system in a powerful, nonspecific way, enhancing cancer treatment outcomes. If confirmed, the discovery could lead to a universal cancer vaccine and transform oncology care.
In trials, in 708 women, when combined with hormone therapy, the drug doubled the time the cancer took to grow, from 3.6 months to 7.3 months, and shrank tumours in 23% of patients.